The cardiovascular risk of young women with polycystic ovary syndrome: An observational, analytical, prospective case-control study

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 8, 2004, Pages 3696-3701

  Orio Jr , Francesco ^a   Palomba, Stefano ^b   Spinelli, Letizia ^a   Cascella, Teresa ^a   Tauchmanovà, Libuse ^a   Zullo, Fulvio ^b   Lombardi, Gaetano ^a   Colao, Annamaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CHOLESTEROL; ESTRADIOL; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYPROGESTERONE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROLACTIN; TESTOSTERONE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM ENLARGEMENT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; M MODE ECHOCARDIOGRAPHY; METABOLIC PARAMETERS; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART RATE; HORMONES; HUMANS; LIPIDS; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; RISK ASSESSMENT;

FALLOPIA;

EID: 4043104723     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-032049     Document Type: Article

References (64)

1. Franks S 1995 Polycystic ovary syndrome. N Engl J Med 333:853-861
2. Scarpitta AM, Sinagra D 2000 Polycystic ovary syndrome: an endocrine and metabolic disease. Gynecol Endocrinol 14:392-395
3. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800
4. Lobo RA, Carmina E 2000 The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 132:989-993
5. Chang RJ, Nakamura RM, Judd HL, Kaplan SA 1983 Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 57:356-359
6. Franks S 2001 Are women with polycystic ovary syndrome at increased risk of cardiovascular disease? Too early to be sure, but not too early to act! Am J Med 111:665-666
7. Ovalle F, Azziz R 2002 Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril 77:1095-1105
8. Holte J, Gennarelli G, Berne C, Bergh T, Lithell H 1996 Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state? Hum Reprod 11:23-28
9. Wild RA, Painter PC, Coulson PB, Carruth KB, Ranney GB 1985 Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 61:946-951
10. Cibula D, Cifkova R, Fanta M, Poledne R, Zivny J, Skibova J 2000 Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension, and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod 15:785-789
11. Birdsall MA, Farquhar CM, White HD 1997 Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med 126:32-35
12. Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy II PF, Fitzpatrick LA 2003 Prevalence and predictors of coronary artery disease calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:2562-2568
13. Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A 1992 Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 71:599-604
14. Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K, Kuller L 1995 Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15:821-826
15. Conway GS, Agrawal R, Betteridge DJ, Jacobs HS 1992 Risk factors for coronary heart disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) 37:119-125
16. Talbott E, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JV, Remsberg KE, Kuller LH 2000 Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 20:2414-2421
17. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, Baron AD 2001 Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 103:1410-1415
18. Kelly CJG, Speirs A, Gould GW, Petrie JR, Lyall H, Connell JMC 2002 Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 87:742-746
19. Harjai KJ 1999 Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen. Ann Intern Med 131:376-386
20. Levy D, Garrison RH, Savage DD, Kannell WB, Castelli WP 1991 Prognostic implication of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561-1566
21. Koren MJ, Devereux RB, Casale PN, Savane DD, Laragh JH 1991 Relation of the left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114:345-352
22. Vaccaro O, Cardoni O, Cuomo V, Panarelli W, Laurenzi M, Mancini M, Riccardi G, Zanchetti A 2003 Relationship between plasma insulin and left ventricular mass in normotensive participants of the Gubbio study. Clin Endocrinol (Oxf) 58:316-322
23. de Simone G, Pasanisi F, Contaldo F 2001 Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension 38:13-18
24. de Simone G, Devereux RB, Roman MJ, Halderman MH, Laragh JH 1994 Relation of obesity and gender to left ventricular hypertrophy in normotensive adults. Hypertension 23:600-606
25. Ferriman D, Gallwey JD 1961 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440-1447
26. Fulghesu AM, Ciampelli M, Belosi C, Apa R, Pavone V, Lanzone A 2001 A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. Fertil Steril 76:326-331
27. Balen AH, Laven JSE, Tan S-L, Dewailly D 2003 Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9:505-514
28. Orio Jr F, Palomba S, Colao A, Tenuta M, Dentico C, Peretta M, Lombardi G, Nappi C, Orio F 2001 Growth hormone secretion after baclofen administration in different phases of the menstrual cycle in healthy women. Horm Res 55:131-136
29. Azziz R, Zacur HA 1989 21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis. J Clin Endocrinol Metab 69:577-584
30. Colao A, Pivonello P, Spiezia S, Faggiano A, Ferone D, Filippella, Marzullo P, Cerbone G, Siciliani M, Lombardi G 1999 Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 84:2664-2672
31. 1983 Obesity. A report of the Royal College of Physicians. J R Coll Physicians Lond 17:5-65
32. Yanovski SZ 1993 A practical approach to treatment of the obese patient. Arch Fam Med 2:309-316
33. Castelli WP 1996 Lipid, risk factors and ischaemic heart disease. Atherosclerosis 124(Suppl):S1-S9
34. Consensus Conference 1984 Treatment of hypertriglyceridemia. JAMA 251:1196-1200
35. Expert Panel: Report of the National Cholesterol Education 1988 Program expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med 148:36-39
36. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 1997 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197
37. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
38. Feigenbaum H 1979 Echocardiography, 2nd ed. Philadelphia: Lea and Febiger
39. Quinones MA, Waggoner AD, Reduto LA, Nelson JG, Young JB, Winters Jr WL, Ribeiro LG, Miller RR 1981 A new simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 64:744-753
40. Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, Miller DH, Reis G, Alderman MH, Laragh JH 1984 Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 4:1222-1230
41. Orio Jr F, Palomba S, Colao A, Russo T, Dentico C, Tauchmanovà L, Savastano S, Nappi C, Sultan C, Zullo F, Lombardi G 2003 GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome. J Endocrinol Invest 26:117-122
42. Orio Jr F, Lucidi P, Palomba S, Tauchmanovà L, Cascella T, Russo T, Zullo F, Colao A, Lombardi G, De Feo P 2003 Circulating ghrelin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab 88:942-945
43. Orio Jr F, Palomba S, Di Biase S, Colao A, Tauchmanovà L, Savastano S, Labella D, Russo T, Zullo F, Lombardi G 2003 Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:673-679
44. Morley JE, Patrick P, Perry III HM 2002 Evaluation of assays available to measure free testosterone. Metabolism 5:554-559
45. Palomba S, Affinito P, Tommaselli GA, Nappi C 1998 A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata. Fertil Steril 70:111-118
46. Palomba S, Affinito P, Di Carlo C, Bifulco G, Nappi C 1999 Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: effectiveness and effects on vasomotor symptoms, bone mass, and lipid profiles. Fertil Steril 72:889-895
47. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
48. Yarali H, Yildirir A, Aybar F, Kabakci G, Bukulmez O, Akgul E, Oto A 2001 Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril 76:511-516
49. Tiras MB, Yalcin R, Noyan V, Maral I, Yildirim M, Dortlemez O, Daya S 1999 Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome. Hum Reprod 14:1949-1952
50. Amowitz LL, Sobel BE 1999 Cardiovascular consequences of polycystic ovary syndrome. Endocrinol Metab Clin North Am 28:439-458
51. Arslanian SA, Lewy VD, Danadian K 2001 Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 86:66-71
52. Legro RS 2003 Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 24:302-312
53. Wild RA 1995 Obesity, lipids, cardiovascular risk and androgen excess. Am J Med 98:27S-32S
54. De Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH 1992 Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251-1260
55. McFarlane SI, Banerji M, Sowers JR 2001 Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 86:713-718
56. Vetta F, Cicconetti P, Ronzoni S, Rizzo V, Palleschi L, Canarile G, Lupattelli MR, Migliori M, Morelli S, Marigliano V 1998 Hyperinsulinaemia, regional adipose tissue distribution and left ventricular mass in normotensive, elderly, obese subjects. Eur Heart J 19:326-331
57. Pyorala K 1979 Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2:131-141
58. Welborn TA, Wearne K 1979 Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2:154-160
59. Ducimentiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G 1980 Relationship of plasma insulin level to the incidence of myocardial infarction and coronary heart disease. Diabetologia 19:205-210
60. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwége E 1991 Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15 year follow-up. Diabetologia 34:356-361
61. Reaven GM 1988 Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607
62. Zimmermann S, Phillips RA, Dunaif A, Finegood DT, Wilkenfeld C, Ardeljan M, Gorlin R, Krakoff LR 1992 Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance. J Clin Endocrinol Metab 75:508-513
63. Prelevic GM, Beljic T, Balint-Peric L, Ginsburg J 1995 Cardiac flow velocity in women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) 43:677-681
64. Rajkhowa M, Glass MR, Rutherford AJ, Michelmore K, Balen AH 2000 Polycystic ovary syndrome: a risk factor for cardiovascular disease? Br J Obstet Gynaecol 107:11-18